Why the study?
Does lymphocyte-to-monocyte ratio on admission predict in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with STEMI after primary PCI?
Population
306 patients with ST-elevated myocardial infarction after primary percutaneous coronary intervention
Comparison
Lymphocyte-to-monocyte ratio (LMR) on admission vs Tertiles of LMR
Design
Cohort
Follow-up
median 21 months (1-36 months)
Authors
Loading...
May aid risk stratification in STEMI post-PCI; leaves open prospective validation before clinical adoption.
Does lymphocyte-to-monocyte ratio on admission predict in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with STEMI after primary PCI?
A lower lymphocyte-to-monocyte ratio on admission is an independent predictor of increased in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with STEMI undergoing primary PCI.
Wang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: